ogx-427
Showing 1 - 7 of 7
Prostate Cancer, Metastatic Castrate-Resistant Prostate Cancer, PSA Trial in Canada, United States (OGX-427, Abiraterone
Terminated
- Prostate Cancer
- +2 more
- OGX-427
- +2 more
-
Marina Del Rey, California
- +15 more
Jul 7, 2022
Bladder Cancer, Urothelial Carcinoma Trial in United States (OGX-427, Docetaxel)
Completed
- Bladder Cancer
- Urothelial Carcinoma
- OGX-427
- Docetaxel
-
Birmingham, Alabama
- +34 more
Jul 7, 2022
Castration Resistant Prostate Cancer Trial in Canada, United States (OGX-427, Prednisone)
Completed
- Castration Resistant Prostate Cancer
- OGX-427
- Prednisone
-
Seattle, Washington
- +5 more
Feb 12, 2019
Non Squamous Non Small Cell Lung Cancer Trial in United States (OGX-427, Placebo)
Completed
- Non Squamous Non Small Cell Lung Cancer
- OGX-427
- Placebo
-
Denver, Colorado
- +15 more
Jun 6, 2018
Pancreatic Cancer Trial in United States (OGX-427, Placebo)
Completed
- Pancreatic Cancer
- OGX-427
- Placebo
-
San Francisco, California
- +10 more
Apr 11, 2017
Bladder Cancer Trial in Vancouver (OGX-427)
Unknown status
- Bladder Cancer
- OGX-427
-
Vancouver, British Columbia, CanadaThe Prostate Centre at Vancouver General Hospital
Feb 10, 2012